Why did these ASX shares outperform their peers in 2025?

Did you snap up any of these stocks this year?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • ASX materials and defence shares soared in 2025 due to rising commodity prices and increased global defence investment, despite a modest overall market gain of 6%.
  • Two of the healthcare sector's top performers were 4DMedical and Racura Oncology, which defied broader sector struggles. 
  • Despite tech sector challenges, Elsight and Energy One surged thanks to major contracts and strong financial growth.

It has been a modest year for the S&P/ASX 200 Index (ASX: XJO) in 2025, with an approximate gain of 6%. ASX materials and defence shares have been a real winner thanks to soaring commodity prices and global defence investment. 

On the flip side, it's been a tough year for Australian technology and healthcare shares. 

The S&P/ASX All Technology Index (ASX: XTX) has dropped almost 11% in 2025, including more than 20% since October. 

Similarly, the S&P/ASX 200 Health Care Index (ASX: XHJ) is down more than 24% since January. 

But amidst these struggling sectors have been some diamonds in the rough. 

Let's look at some of the winners from these two sectors in 2025. 

A team celebrates a win in the office.

Image source: Getty Images

Healthcare winners

One of the best performing ASX shares in 2025 has been 4DMedical Ltd (ASX: 4DX). 

The medical technology company works in the field of respiratory imaging and ventilation analysis in the treatment of lung and respiratory diseases.

The Motley Fool's Aaron Teboneras reported earlier this month on the consistent run of positive results and milestones hit by the company this year. 

Regulatory approvals and new commercial partnerships have expanded its markets and validated its technology, shifting investor views from speculative potential to increasingly visible and growing software revenue.

This has launched the stock almost 680% higher in 2025. 

Despite this unbelievable run, it's still drawing optimism for future growth.

Another healthcare stock winner this year has been Racura Oncology Ltd (ASX: RAC). 

It is an Australian clinical-stage biopharmaceutical company focused on developing cancer treatments.

It has risen almost 100% in 2025, meaning investors almost doubled their returns holding this stock through the year. 

This has been driven by promising scientific research and private placement offers.

Technology winners

Meanwhile, in the technology sector, one of the best-performing ASX shares has been Elsight Ltd (ASX: ELS). 

The company technically sits in the information technology sector, but has risen thanks to tailwinds in the defence sector. 

The company offers advanced communication components for unmanned systems (aerial, ground, and sea) through its flagship product – the Halo platform. 

Its rise has been fuelled by major contract wins, including a US$21.2M contract for CY2026. 

CY25e also marked a pivotal inflection point for the company, achieving profitability and delivering estimated revenue growth of 12x YoY (BPe). 

Its share price has risen by more than 750% this year. 

Finally, another technology stock that has enjoyed a stellar year is Energy One Ltd (ASX: EOL). 

It is a supplier of software products and services to wholesale energy, environmental, and carbon trading markets.

It reported strong growth in the 2025 financial year, reporting revenue growth of 17% to $61.4 million and annual recurring revenue (ARR) rising 22% to $60.4 million.

Its share price is up more than 150% this year. 

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Energy One. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Business people discussing project on digital tablet.
Broker Notes

Buy, hold, sell: AGL, Origin Energy, and Woodside shares

Here's what analysts at Shaw and Partners think of these shares.

Read more »

Man with his head in his head because of falling share price.
Share Market News

These are the 10 most shorted ASX shares

Let's see which shares short sellers are targeting this week.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Share Market News

5 ASX 200 shares that could be a bargain right now

These shares could be too weak to ignore.

Read more »

a judge sitting in a blurred background reaches forward to strike his gavel on the strikeplate on his judge's bench.
Share Market News

Brambles shares: Class action judgment update

Brambles has received a ruling on its shareholder class action, with most claims dismissed and financial implications still unclear.

Read more »

A young joyful couple is watching a movie with their daughter in the cinema.
Opinions

Why this ASX 300 share could rise by 24% according to experts

A fund manager thinks this business has a lot of growth potential!

Read more »

Smiling man with phone in wheelchair watching stocks and trends on computer
Share Market News

5 things to watch on the ASX 200 on Monday

It looks set to be a good session for Aussie investors today.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in his 30s with a clipped beard sits at his laptop on a desk with one finger to the side of his face and his chin resting on his thumb as he looks concerned while staring at his computer screen.
Broker Notes

Buy, hold, sell: Life360, Northern Star, and Sigma shares

Are these popular shares buys? Here's how analysts rate them.

Read more »